Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Interest Coverage Ratio (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Interest Coverage Ratio of 3.02 for Q2 2026, down 22087.84% on a QoQ basis from 0.01 in Q1 2026, and up 85.68% year-over-year from 1.62 in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Interest Coverage Ratio (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Interest Coverage Ratio for 18 years, with the latest figure at 3.02 in Q2 2026.

  • On a quarterly basis, Interest Coverage Ratio rose 85.68% year-over-year to 3.02 in Q2 2026; TTM through Jun 2026 was 0.21, a 84.3% decrease from a year earlier, with the FY2026 full-year figure at 13.52, up 46.24% from the prior year.
  • Interest Coverage Ratio was 3.02 for Q2 2026 at Dr Reddys Laboratories, down from 0.01 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 100.0 in Q3 2022, with the low at 50.61 in Q3 2023.
  • Average Interest Coverage Ratio over 5 years is 12.87, with a median of 20.18 recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio surged 358.86% in 2022, then slumped 390.03% in 2023.
  • Over 5 years, Interest Coverage Ratio stood at 15.1 in 2022, then sank by 190.23% to 43.82 in 2023, then soared by 47.78% to 22.89 in 2024, then surged by 100.74% to 0.17 in 2025, then slumped by 1880.21% to 3.02 in 2026.
  • The last three Interest Coverage Ratio figures came in at 3.02 (Q2 2026), 0.01 (Q1 2026), and 0.17 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 0.05
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 3.02
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 1.87
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -1.79
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 5.97
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 579.00
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.02
Mar 31, 2026 0.01
Dec 31, 2025 0.17
Sep 30, 2025 -19.31
Jun 30, 2025 -21.05
Mar 31, 2025 0.31
Dec 31, 2024 -22.89
Sep 30, 2024 -23.18
Jun 30, 2024 -29.97
Mar 31, 2024 -25.23
Dec 31, 2023 -43.82
Sep 30, 2023 -50.61
Jun 30, 2023 -14.33
Mar 31, 2023 -23.56
Dec 31, 2022 -15.10
Sep 30, 2022 100.00
Jun 30, 2022 -35.19
Mar 31, 2022 -4.81
Dec 31, 2021 -26.14
Sep 30, 2021 -38.63